In his research, Sharan Kumar Reddy Bobbala, PhD, used lipid nanoparticles to deliver adjuvants, which are molecules in vaccines that work to stimulate the immune system — directly to white blood cells.
This method, Dr. Bobbala said in the Feb. 21 news release, could “allow enhanced and more durable immune responses with lower vaccine doses.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
